UniSa - IRIS Institutional Research Information System

BIFULCO, Maurizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.037
EU - Europa 1.799
AS - Asia 1.268
OC - Oceania 8
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 2
Totale 10.129
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.023
CN - Cina 634
UA - Ucraina 612
VN - Vietnam 425
IT - Italia 423
SE - Svezia 207
IE - Irlanda 206
TR - Turchia 169
DE - Germania 161
FI - Finlandia 111
IN - India 31
GB - Regno Unito 21
RU - Federazione Russa 17
CA - Canada 12
FR - Francia 11
EU - Europa 7
ES - Italia 5
NL - Olanda 5
AU - Australia 4
NZ - Nuova Zelanda 4
SK - Slovacchia (Repubblica Slovacca) 4
BE - Belgio 3
BR - Brasile 3
CH - Svizzera 3
ID - Indonesia 3
PE - Perù 3
IL - Israele 2
IR - Iran 2
PL - Polonia 2
AL - Albania 1
AT - Austria 1
CI - Costa d'Avorio 1
CL - Cile 1
CM - Camerun 1
CO - Colombia 1
DK - Danimarca 1
HK - Hong Kong 1
HR - Croazia 1
HU - Ungheria 1
MD - Moldavia 1
MX - Messico 1
PA - Panama 1
PH - Filippine 1
RO - Romania 1
RS - Serbia 1
Totale 10.129
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.160
Chandler 905
Jacksonville 751
Princeton 590
Woodbridge 540
Dong Ket 424
Wilmington 394
Houston 300
Dublin 206
Nanjing 194
Izmir 169
Ashburn 158
Andover 132
Boardman 120
Pellezzano 118
Beijing 97
Salerno 80
Nanchang 55
Shenyang 55
Fairfield 54
Hebei 46
Jiaxing 42
Norwalk 42
Mestre 40
Changsha 34
Pune 29
Tianjin 25
Dearborn 19
Düsseldorf 19
Jinan 18
Shanghai 16
San Diego 15
Washington 14
Los Angeles 12
Qualiano 12
Redwood City 12
West Jordan 12
Zhengzhou 11
Cambridge 10
Seattle 10
Rome 8
Bari 7
Nürnberg 7
Ottawa 7
Hangzhou 6
Lanzhou 6
Milan 6
Avellino 5
Falls Church 5
Indiana 5
Duncan 4
Guangzhou 4
Madrid 4
San Nicola la Strada 4
Settimo Milanese 4
Tappahannock 4
Amsterdam 3
Bologna 3
Brussels 3
Casalnuovo Di Napoli 3
Ferrandina 3
Haikou 3
Hefei 3
Lappeenranta 3
Marano di Napoli 3
Menlo Park 3
Naples 3
Napoli 3
Phoenix 3
Serang 3
Stockholm 3
Zurich 3
Altavilla Silentina 2
Ancona 2
Benevento 2
Casoria 2
Castellammare Di Stabia 2
Catania 2
Chengdu 2
Chiswick 2
Dormagen 2
Frankfurt am Main 2
Fuzhou 2
Giugliano in Campania 2
Hanover 2
Kunming 2
L'aquila 2
Lima 2
London 2
Martin 2
Nagold 2
Nettuno 2
New York 2
Philadelphia 2
Pioltello 2
Pisa 2
Santa Giustina 2
Sarno 2
Venezia 2
Verona 2
Totale 8.130
Salva come PNG Salva come JPEG
Nome #
1,2-Dihydro-2-oxopyridine-3-carboxamides: The C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptor 196
Binding of the hemopressin peptide to the cannabinoid CB(1) receptor: structural insights. 131
Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor. 124
Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation 118
Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects 112
Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells. 110
A new strategy to block tumor growth by inhibiting endocannabinoid inactivation 109
Structural Evidence ofN6-Isopentenyladenosine As a New Ligand of Farnesyl Pyrophosphate Synthase 106
Immune-Modulation and Properties of Absorption and Blood Brain Barrier Permeability of 1,8-Naphthyridine Derivatives. 105
Thyroid adiponcosis: more than an hypothesis 104
“Adiponcosis”: A New Term to Name the Obesity and Cancer Link 102
Anti-tumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. 100
The cannabinoid CB1 receptor antagonist Rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating phosphatidylinositol-3-kinase activity. 100
Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis 100
Immunomodulatory properties of 1,2-dihydro-4-hydroxy-2-oxo-1,8-naphthyridine-3-carboxamide derivative VL15 99
The isoprenoid derivative N6-benzyladenosine (CM223) exerts antitumor effect in glioma patient-derived primary cells through the mevalonate pathway 96
Effects on immune cells of a new 1,8-naphthyridin-2-one derivative and its analogues as selective CB2 agonists: implications in multiple sclerosis 95
Antitumor effect of pyrrolo-1,5-benzoxazepine-15 and its synergistic effect with Oxaliplatin and 5-FU in colorectal cancer cells. 94
The endocannabinoid signaling system in cancer 93
Brain cancer risk: the weight of obesity 93
Association between Cannabinoid type-1 receptor polymorphism and body mass index in a Southern Italian population. Int J Obesity 92
Dental care and dentistry practice in the Medieval Medical School of Salerno 91
N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic flux 91
Leucine enhances aerosol performance of Naringin dry powder and its activity on cystic fibrosis airway epithelial cells 89
Applicazione degli inibitori della prenilazione nelle patologie proliferative della tiroide: la lovastatina induce apoptosi in cellule tiroidee umane. 89
Anti Proliferative and Pro Apoptotic Effects of Flavonoid Quercetin Are Mediated by CB1 Receptor in Human Colon Cancer Cell Lines 88
Arvanil and anandamide up-regulate CD36 expression in human peripheral blood mononuclear cells. 87
Phytocannabinoids and cannabimimetic drugs: Recent patents in central nervous system disorders 87
The right to care and the expectations of society?controversial stem cell therapy in Italy 87
Interaction of endocannabinoid system and steroid hormones in the control of colon cancer cell growth. 85
Apoptosis induced by denied adhesion to extracellular matrix (anoikis) in thyroid epithelial cells is p53 dependent but fails to correlate with modulation of p53 expression. 84
The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism. 84
Serum withdrawal-induced apoptosis in thyroid cells is caused by loss of fibronectin-integrin interaction. 83
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients’ cells 83
Statins and cancer in gastroenterology: new insight? 81
Anandamide drives cell cycle progression through CB1 receptors in a rat model of synchronized liver regeneration. 81
Cannabidiol: State of the art and new challenges for therapeutic applications 80
Anandamide inhibits Cdk2 and activates Chk1 leading to cell cycle arrest in human breast cancer cells. 78
Antiangiogenic activity of the endocannabinoid anandamide. Correlation to its tumour-suppressor efficacy 78
Cannabinoid Type 1 Receptor Gene Polymorphism and Macronutrient Intake. 78
Statins and cancer-related mortality: an open question. 77
N6-isopentenyladenosine improves nuclear shape in fibroblasts from humans with progeroid syndromes by inhibiting the farnesylation of prelamin A 77
Updates on Adiponcosis: More new incoming evidence strengthening the obesity-cancer link 77
The basis of the modern medical hygiene in the medieval Medical School of Salerno 75
v-K-ras leads to preferential farnesylation of p21ras in FRTL-5 cells: multiple interference with the isoprenoid pathway 74
Statins in neurological disorders: an overview and update 74
Drug screening on Hutchinson Gilford progeria pluripotent stem cells reveals aminopyrimidines as new modulators of farnesylation 73
Modern History of Medical Cannabis: From Widespread Use to Prohibitionism and Back 73
17-beta estradiol overcomes a G1 block induced by HMG-CoA reductase inhibitors and fosters cell cycle progression without inducing Erk-1 and -2 MAP kinases activation 72
Lovastatin induces apoptosis of k-ras-transformed thyroid cells via inhibition of ras farnesylation and by modulating redox state. 72
The HMG-CoA reductase inhibitor lovastatin induces apoptosis in proliferating human thyroid cells. 71
Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon 71
Mediterranean diet: The missing link between gut microbiota and inflammatory diseases 70
Verminoside- and verbascoside-induced genotoxicity on human lymphocytes: involvement of PARP-1 and p53 proteins. 69
Identification of CM223 as a new ligand of farnesyl pyrophosphate synthase with improved antiglioma action 69
Statin reduces orbitopathy risk in patients with Graves’ disease by modulating apoptosis and autophagy activities 69
End of the line for cannabinoid receptor 1 as an anti-obesity target? An opinion. 68
Inhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by Rimonabant: a therapeutic target for colon cancer 67
Rimonabant (SR141716) exerts anti-proliferative and immunomodulatory effects in human peripheral blood mononuclear cells. 66
Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells. 66
Effects of olive oil polyphenols on fatty acid synthase gene expression and activity in human colorectal cancer cells. 66
Rimonabant reduces keratinocyte viability by induction of apoptosis and exerts topical anti-inflammatory activity in mice. 66
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity. 66
N(6)-isopentenyladenosine inhibits cell proliferation and induces apoptosis in a human colon cancer cell line DLD1 65
Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents 65
Biological and pharmacological roles of N6-isopentenyladenosine: an emerging anticancer drug 65
Molecular mechanisms responsible for neuroinflammation and neurological impairments in mevalonate kinase deficiency 64
Deregulated expression and activity of Farnesyl Diphosphate Synthase (FDPS) in Glioblastoma 64
The new task for medical scientists 64
The isoprenoid end product N6-isopentenyladenosine reduces inflammatory response through the inhibition of the NFκB and STAT3 pathways in cystic fibrosis cells 63
The anandamide analogue, Met-F-AEA, controls human breast cancer cell migration via the RhoA/Rho kinase signaling pathway. 62
Structures and micelle locations of the nonlipidated and lipidated C-terminal membrane anchor of 2',3'-cyclic nucleotide-3'-phosphodiesterase. 61
Plasma membrane and lysosomal localization of CB1 cannabinoid receptor are dependent on lipid rafts and regulated by anandamide in human breast cancer cells. 60
The endocannabinoid system and its therapeutic exploitation. 60
Cannabinoids and cancer: pros and cons of an antitumour strategy. 60
Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin. 60
Rimonabant: just an antiobesity drug? Current evidence on its pleiotropic effects. (review) 59
Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression 59
Politics and Research: a desirable and essential dialogue 59
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation 58
A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines by activation of apoptosis. 58
Breast adiponcosis: a call for further research 58
Fatty acid synthase hyperactivation in human colorectal cancer: relationship with tumor side and sex. 58
The N-Terminal Domain of 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase Harbors a GTP/ATP Binding Site. 58
Comment on “the negative impact of being underweight and weight loss on survival of children with acute lymphoblastic leukemia.” 58
Cannabinoids in the management of spasticity associated with multiple sclerosis 57
Statins for inflammatory bowel disease: Can off-label drug help it? 57
HMG-CoA reductase inhibitors inhibit rat propylthiouracil-induced goiter by modulating the ras-MAPK pathway. 56
Capsaicin-like effects of N-arachidonoyl-dopamine in the isolated guinea pig bronchi and urinary bladder 56
Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB(1)/CB(2) receptors. 56
Concomitant BRAFV600E mutation and RET/PTC rearrangement is a frequent occurrence in papillary thyroid carcinoma. 56
What we know and do not know about the cannabinoid receptor 2 (CB2) 56
A new role of anandamide in human sperm: focus on metabolism 56
Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion (review). 55
Rimonabant-induced apoptosis in leukemia cell lines: Activation of caspase-dependent and -independent pathways 55
The CB1 receptor antagonist rimonabant controls cell viability and ascitic tumour growth in mice. 55
Oxylipins from Dracontium loretense. 55
N6-isopentenyladenosine affects cytotoxic activity and cytokines production by IL-2 activated NK cells and exerts topical anti-inflammatory activity in mice 55
Risk of diabetes with statins must be monitored in each patient 55
Antibiotics exposure in obesity: an update of a complex relationship 55
Totale 7.684
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.620
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.620
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019210 0 0 0 0 0 0 0 0 0 0 203 7
2019/20201.352 428 22 159 4 97 16 115 16 113 141 220 21
2020/20211.352 24 119 111 5 146 58 142 6 121 1 147 472
2021/20221.029 6 3 2 14 53 14 3 47 141 145 147 454
2022/20231.885 173 145 14 279 275 384 10 185 267 13 82 58
2023/2024494 69 105 42 30 48 114 14 28 8 35 1 0
Totale 10.430